|
[news 1999-2000]
$7
million venture capital fund created to commercialize
biotechnology discoveries at Queen's
February 15, 1999
KINGSTON, ON -- Researchers and scientists at Queen's
University received a boost today with the launch of
the Working Ventures CMDF Queen's Scientific Breakthrough
Fund. The $7 million venture fund will invest in enterprises
formed by Queen's researchers looking to protect, commercialize
and market health and life sciences research discoveries.
The Working Ventures CMDF Queen's Scientific Breakthrough
Fund is the second fund to be launched under the Ontario
Government's Community Small Business Investment Fund
(CSBIF) Program. Established as a partnership between
Queen's University, Working Ventures Canadian Fund,
the new Fund will be managed by PARTEQ, Queen's technology
transfer arm.
The program was founded to provide a local source of
capital to small, high-growth businesses and to provide
stimulus for investment partnerships between investment
pools, universities and their local communities.
The fund will make initial investments of up to $250,000
and follow-on investments of up to a total of $1.4 million
in companies with less than $1 million in assets. While
the fund will focus on investing in biotechnology and
health and life sciences enterprises, researchers from
other technology fields could also qualify.
Initial capitalization of the fund consists of $5 million
from Working Ventures Canadian Fund, Canada's largest
national venture capital fund, and $2 million from the
Canadian Medical Discoveries Fund, the largest venture
investor in Canada's life sciences sector.
"This is a great vote of confidence in PARTEQ,"
says John Molloy, President and Chief Executive Officer.
"PARTEQ has the management infrastructure, expertise,
proven capability and access to intellectual property
which makes it an ideal partner to manage a venture
fund under this innovative government program. This
is incredibly exciting for Queen's and also for the
local community. This is the first time Kingston has
had access to a captive venture fund and this presents
great possibilities for economic stimulation of the
local economy."
Ron Begg, President of Working Ventures says, "There
is a critical need for patient capital, strategic management
and business development expertise to help drive discoveries
into the commercial pipeline. Working Ventures and our
partners in this fund bring the necessary resources
required to help boost Canadian health and life sciences
advances and make money for our shareholders."
Dr. Calvin Stiller, Chairman and CEO of Canadian Medical
Discoveries Fund, says "this is the first of CMDF's
investments in a community-based small business investment
fund. We are delighted to see this at Queen's where
CMDF and its affiliated company, University Medical
Discoveries Inc., have already worked with scientists
and invested in a number of technologies under development
there. We look forward to this collaborative endeavour,
and to the establishment of others throughout the province."
Ontario Minister of Energy, Science and Technology,
Jim Wilson, welcomes the announcement of Working Ventures
CMDF Queen's Scientific Breakthrough Fund. "Investments
like these help stem the 'brain drain' and keep Ontario
on the leading edge of biomedical research," says
Minister Wilson. "Funding start-up research firms
will create jobs for some of our best and brightest
young minds."
PARTEQ's primary mission is to maximize return through
the commercialization of intellectual property owned
or assigned to Queen's University. PARTEQ spin-off companies
have raised more than $55 million over the last three
years to develop technologies discovered through research
at Queen's. PARTEQ has helped create more than 125 jobs
and currently estimates the value of its spin-off efforts
at more than $175 million.
Queen's Principal, William Leggett, says he is delighted.
"Queen's showed great foresight in 1987 in creating
PARTEQ to explore the potential commercial value of
university discoveries. We have seen, in a very short
time, some amazing results and there is every reason
to believe that Queen's researchers and the Kingston
economy will continue to benefit greatly."
Contact:
John Molloy
President and CEO
PARTEQ Innovations
Phone: (613) 533-2342
Email: molloyj@post.queensu.ca
|